187 related articles for article (PubMed ID: 32628016)
1. An Ultrasmall RuO
Liu Z; Xie L; Qiu K; Liao X; Rees TW; Zhao Z; Ji L; Chao H
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31205-31216. PubMed ID: 32628016
[TBL] [Abstract][Full Text] [Related]
2. Ceria Nanozymes with Preferential Renal Uptake for Acute Kidney Injury Alleviation.
Zhang DY; Liu H; Li C; Younis MR; Lei S; Yang C; Lin J; Li Z; Huang P
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56830-56838. PubMed ID: 33319561
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury.
Bao B; Liu H; Han Y; Xu L; Xing W; Li Z
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16460-16470. PubMed ID: 36946292
[TBL] [Abstract][Full Text] [Related]
4. Protein-Supported RuO
He SB; Balasubramanian P; Chen ZW; Zhang Q; Zhuang QQ; Peng HP; Deng HH; Xia XH; Chen W
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14876-14883. PubMed ID: 32155045
[TBL] [Abstract][Full Text] [Related]
5. Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.
Zhang DY; Tu T; Younis MR; Zhu KS; Liu H; Lei S; Qu J; Lin J; Huang P
Theranostics; 2021; 11(20):9904-9917. PubMed ID: 34815794
[No Abstract] [Full Text] [Related]
6. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
7. Phenylenediamine-Based Carbon Nanodots Alleviate Acute Kidney Injury via Preferential Renal Accumulation and Antioxidant Capacity.
Gao J; Liu Y; Jiang B; Cao W; Kan Y; Chen W; Ding M; Zhang G; Zhang B; Xi K; Jia X; Zhao X; Guo H
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31745-31756. PubMed ID: 32571010
[TBL] [Abstract][Full Text] [Related]
8. pH-Activatable Pre-Nanozyme Mediated H
Jiang W; Hou X; Qi Y; Wang Z; Liu Y; Gao XJ; Wu T; Guo J; Fan K; Shang W
Adv Sci (Weinh); 2024 May; 11(18):e2303901. PubMed ID: 38445847
[TBL] [Abstract][Full Text] [Related]
9. Multi-enzyme mimetic ultrasmall iridium nanozymes as reactive oxygen/nitrogen species scavengers for acute kidney injury management.
Zhang DY; Younis MR; Liu H; Lei S; Wan Y; Qu J; Lin J; Huang P
Biomaterials; 2021 Apr; 271():120706. PubMed ID: 33607543
[TBL] [Abstract][Full Text] [Related]
10. Silver-gold-apoferritin nanozyme for suppressing oxidative stress during cryopreservation.
Dashtestani F; Ghourchian H; Najafi A
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():831-840. PubMed ID: 30423769
[TBL] [Abstract][Full Text] [Related]
11. Nanozymes: From New Concepts, Mechanisms, and Standards to Applications.
Liang M; Yan X
Acc Chem Res; 2019 Aug; 52(8):2190-2200. PubMed ID: 31276379
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases.
Liu T; Xiao B; Xiang F; Tan J; Chen Z; Zhang X; Wu C; Mao Z; Luo G; Chen X; Deng J
Nat Commun; 2020 Jun; 11(1):2788. PubMed ID: 32493916
[TBL] [Abstract][Full Text] [Related]
13. Prussian blue-based theranostics for ameliorating acute kidney injury.
Zhang DY; Liu H; Zhu KS; He T; Younis MR; Yang C; Lei S; Wu J; Lin J; Qu J; Huang P
J Nanobiotechnology; 2021 Sep; 19(1):266. PubMed ID: 34488789
[TBL] [Abstract][Full Text] [Related]
14. Studies on fate and toxicity of nanoalumina in male albino rats: Oxidative stress in the brain, liver and kidney.
Morsy GM; Abou El-Ala KS; Ali AA
Toxicol Ind Health; 2016 Feb; 32(2):200-14. PubMed ID: 24081632
[TBL] [Abstract][Full Text] [Related]
15. SOD mineralized zeolitic imidazole framework-8 for the treatment of chemotherapy-related acute kidney injury.
Zhang D; Wang Y; Bi L; Liu H; Ding X
Colloids Surf B Biointerfaces; 2023 Sep; 229():113447. PubMed ID: 37536166
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable Self-Assembled Ultrasmall Nanodots as Reactive Oxygen/Nitrogen Species Scavengers for Theranostic Application in Acute Kidney Injury.
Zhang DY; Liu H; He T; Younis MR; Tu T; Yang C; Zhang J; Lin J; Qu J; Huang P
Small; 2021 Feb; 17(8):e2005113. PubMed ID: 33491916
[TBL] [Abstract][Full Text] [Related]
17. An auto-photoacoustic melanin-based drug delivery nano-platform for self-monitoring of acute kidney injury therapy via a triple-collaborative strategy.
Zhao X; Sun J; Dong J; Guo C; Cai W; Han J; Shen H; Lv S; Zhang R
Acta Biomater; 2022 Jul; 147():327-341. PubMed ID: 35643195
[TBL] [Abstract][Full Text] [Related]
18. A Redox Modulatory Mn
Singh N; Savanur MA; Srivastava S; D'Silva P; Mugesh G
Angew Chem Int Ed Engl; 2017 Nov; 56(45):14267-14271. PubMed ID: 28922532
[TBL] [Abstract][Full Text] [Related]
19. Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression.
Liu N; Chen J; Gao D; Li W; Zheng D
Int Urol Nephrol; 2018 Jun; 50(6):1171-1180. PubMed ID: 29368247
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
